PRECISION BIOSCIENCES INC Accounts Payable
PRECISION BIOSCIENCES INC (DTIL) had Accounts Payable of $828.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $828.00K.
- 2026-03-31: Accounts Payable, Current $944.00K.
- 2025-12-31: Accounts Payable, Current $296.00K.
- 2025-09-30: Accounts Payable, Current $1.34M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $828.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $944.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $296.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.34M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $1.12M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $924.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.31M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $958.00K 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $1.14M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $1.14M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $2.97M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $531.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $781.00K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $701.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $653.00K 10-K · filed 2024-03-27 | $1.23M 10-K · filed 2023-03-09 |
| 2022-09-30 | $1.06M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $797.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $699.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.14M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $486.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $478.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $445.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $792.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $959.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $1.59M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.77M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.04M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $4.46M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.88M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $5.06M 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $2.22M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |